Salubris

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Precision Scientific specializes in drug mechanism research services tailored for pharmaceutical and biotechnology firms. Utilizing its proprietary AI technology, ALBERT, the company employs advanced machine learning techniques to analyze multi-omics data. This innovative approach aids in various aspects of oncology research, including drug target discovery, biomarker identification, indication selection, evaluation of drug resistance mechanisms, and the development of combination therapy strategies. Additionally, Precision Scientific offers comprehensive contract research organization (CRO) services that encompass clinical development, biomarker and companion diagnostic development, biometrics, regulatory strategy, and commercialization support, thereby enhancing cancer care for both pharmaceutical companies and healthcare institutions.

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Mercator MedSystems, Inc. is a medical technology company based in Emeryville, California, specializing in catheter-guided microfluid injection systems for the targeted delivery of therapeutic agents. The company offers Cricket and Bullfrog micro-infusion catheters, which facilitate the direct injection of therapies through blood vessel walls into deep tissues. These products address conditions such as blood vessel restenosis, inflammation following vascular injury, and peripheral artery disease. Mercator's technology allows for the infusion of drugs, genes, and cells without compromising their viability or potency, making it suitable for therapies ranging from plaque stabilization in diseased vessels to stem cell transplantation and gene therapies. By enabling site-specific delivery, Mercator MedSystems aims to enhance patient outcomes in vascular disease, oncology, and regenerative medicine, while paving the way for innovative treatments in these areas. The company was established in 1999 and was previously known as Endobionics, Inc.

Viracta Therapeutics, Inc. is a clinical-stage drug development company based in Cardiff, California, that specializes in precision oncology focused on virus-associated malignancies. The company utilizes a viral activation therapy platform to develop treatments for cancers linked to the Epstein-Barr Virus (EBV) and other virus-related diseases. Its lead investigational drug, nanatinostat, is being evaluated in combination with the antiviral valganciclovir as a potential oral therapy for EBV-positive lymphoma, including post-transplant lymphoproliferative disorder, plasmablastic lymphoma, and angioimmunoblastic T cell lymphoma. Viracta is also exploring the application of this approach to other EBV-associated conditions, such as nasopharyngeal carcinoma and gastric carcinoma. Founded in 2007 and rebranded from HemaQuest Pharmaceuticals in 2015, Viracta Therapeutics is actively conducting multiple clinical trials to advance its therapeutic candidates.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company offers a comprehensive range of biological heart valves, focusing on minimally invasive solutions that enhance patient outcomes. Utilizing cutting-edge technologies, including anti-calcification, dry presentation, and leaflet thinning, KingstronBio aims to deliver innovative and effective products to the medical community, thereby addressing critical needs in cardiovascular care.

Jinjiang Electronics is a med-tech company specializing in the research, development, and manufacturing of medical equipment focused on cardiac electrophysiology. The company offers a range of products designed to enhance patient care and improve quality of life for those with heart conditions. Its product lineup includes a 3D cardiac mapping system, electrophysiology recording systems, cardiac RF ablation generators, and irrigation pumps. These offerings provide comprehensive solutions aimed at diagnosing and treating arrhythmias, addressing critical needs in the field of cardiology.

GO Therapeutics specializes in developing innovative antibodies aimed at treating cancer by targeting specific glycoprotein antigens found on tumor cells. The company utilizes a unique approach that combines up-regulated protein expression with abnormal glycosylation patterns to create highly tumor-specific antibodies. This method enhances the precision of cancer immunotherapies, allowing for the targeting of antigens that are absent in healthy cells. By focusing on these tumor-specific markers, GO Therapeutics aims to enable bi-specific antibody T-cell engagement, CAR-T, and antibody-drug conjugate therapies, thus minimizing damage to healthy tissue while effectively combating cancer.

Zhongke Health Industry Group is a manufacturer of health care products. It provides goods for managing blood sugar, nourishing and guarding the liver, combating fatigue, and maintaining cardiovascular and cerebrovascular health. Their products include spore powder capsules, bovine colostrum capsules, and Ganoderma lucidum spore oil.